NL-OMON43524
已完成
不适用
Quantification of Circulating tumor DNA derived Structural variants to assess treatment response in metastatic prostate cancer patients - Circus study
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- prostate cancer
- 发起方
- Erasmus MC, Universitair Medisch Centrum Rotterdam
- 入组人数
- 285
- 状态
- 已完成
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •\- metastasized castration resistant prostate cancer
- •\- participation in CPCT\-02 study
- •\- age \* 18 years
- •\- written informed consent
排除标准
- •\- not meeting the inclusion criteria
结局指标
主要结局
未指定
相似试验
招募中
不适用
Quantification of Circulating tumor DNA to assess treatment response in metastatic prostate cancer patientsmetastatic prostate cancerNL-OMON24467Erasmus Medical Center95
招募中
不适用
Circulating tumor DNA as a noninvasive biomarker in patients with thyroid cancerC73Malignant neoplasm of thyroid glandDRKS00022441niversitätsklinikum Freiburg75
招募中
不适用
Circulating tumor DNA as a noninvasive biomarker in patients with Non-Hodgkin Lymphoma (NHL)C83.3C85Diffuse large B-cell lymphomaOther and unspecified types of non-Hodgkin lymphomaDRKS00024180niversitätsklinikum Freiburg200
已完成
不适用
Prospective Evaluation of Circulating Tumour DNA (ctDNA) as Molecular Monitoring Tool and Prognostic Biomarker in Resectable Pancreatic AdenocarcinomasC25Malignant neoplasm of pancreasDRKS00010992niversitätsklinikum Freiburg25
招募中
不适用
Circulating tumor DNA (ctDNA) analyses as a predictive marker for cancer treatment in solid tumorsKCT0008188Chonnam National University Hospital Hwasun Hospital100